TY  - BOOK
AU  - Hajjaji,Nawale
AU  -  Tredan,Olivier
TI  - Triple-negative breast cancer: From biology to clinical practice
PY  - 2022///.
							
N1  - 68
N2  - Triple-negative breast cancers (TNBC) are a large heterogeneous group of pathological and biologically diverse carcinomas. TNBC may be categorized based on distinct genomic or transcriptional patterns and/or immune characteristics, and classified as basal-like, mesenchymal, and luminal androgen-receptor subtypes. They may be highly infiltrated by immune cells or devoid of them. Molecular alterations should be screened to help define the treatment. Thus, there is a need to adopt a comprehensive view of TNBC biology in order to tailor the therapeutic strategy with targeted agents, including novel antibody-drug conjugates or innovative immunotherapies
UR  - https://shs.cairn.info/journal-innovations-therapeutiques-en-oncologie-2025-HS2-page-5?lang=en&redirect-ssocas=7080
ER  -